Share

March 27, 2018; 90 (13) Article

Epilepsy, antiepileptic drugs, and serious transport accidents

A nationwide cohort study

Heléne E.K. Sundelin, Zheng Chang, Henrik Larsson, Paul Lichtenstein, Catarina Almqvist, Torbjörn Tomson, Jonas F. Ludvigsson
First published February 28, 2018, DOI: https://doi.org/10.1212/WNL.0000000000005210
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
251

Share

Article Information

vol. 90 no. 13 e1111-e1118
DOI: 
https://doi.org/10.1212/WNL.0000000000005210
PubMed: 
29490912
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received July 19, 2017
  • Accepted in final form December 13, 2017
  • First Published February 28, 2018.

Article Versions

Copyright & Usage: 
© 2018 American Academy of Neurology

Author Disclosures

    1. Heléne E.K. Sundelin, PhD*,
    2. Zheng Chang, PhD*,
    3. Henrik Larsson, PhD,
    4. Paul Lichtenstein, PhD,
    5. Catarina Almqvist, PhD,
    6. Torbjörn Tomson, PhD and
    7. Jonas F. Ludvigsson, PhD
  1. Heléne E.K. Sundelin, PhD*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Zheng Chang, PhD*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Henrik Larsson, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Dr. Larsson has served as a speaker for Eli-Lilly and Shire (both outside the submitted work).

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Two research grants from Shire, outside the submitted work

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Paul Lichtenstein, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Paul Lichtenstein has served as a speaker for Medice, a commercial entity. Honorary payment.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. The Swedish Foundation for international Cooperation in Research and Higher Education (STINT): IG2012-5056: 27/06/13 to 31/12/17. Institutional Grant: Genes, environments, and the development of mental health problems Role: PI Swedish Council for Working life & Social Research: 2012-1678: 01/01/13 to 12/31/18 Programme Grant: Genes, environments and the development of mental health and behavior problems from childhood to adulthood. Support for research on development of mental health problems from childhood to adulthood in twins and families. Role:PI Swedish Research Council: 2011-2492: 01/01/12-12/31/16 Genes, environments and the development of mental health and behavior problems from childhood to adulthood Role: PI European Commission: 602768: 06/01/14-05/31/20 ACTION - Aggression in Children: Unraveling gene-environment interplay to inform Treatment and Intervention strategy Role: Partner Swedish Council for Working life and Social Research: 2014-0834: 01/01/15 to 12/31/17 Identifying environmental and genetic risks for the developmental of childhood mental health problems using a large, longitudinal and genotyped twin sample: The CATSS study. Collection of longitudinal data on psychopathology and well-being from twins and their parents at age 15. Role: PI National Institute of Health (U.S): 2 R01 HD056354-04A1: 06/01/11 to 05/31/14 Twin Studies of Marriage Benefit: Parsing Selection from Causation Role: Co-PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Catarina Almqvist, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Clinical and Experimental Allergy, associate editor, 2009-2014 (2) Acta Paediatrica, editorial committee, 2012-ongoing

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Alm J, Almqvist C, Emenius. Milj?ns betydelse f?r allergi och astma. Astma och allergi hos barn Studentlitteratur, 2014.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Swedish Research Council SIMSAM framework grant no 340-2013-5867, PI, 2014-2018 (2) FORTE grant no 2015-00289, PI, 2016-2018 (3) Swedish Heart and Lung Foundation grant no 20150440, PI, 2016-2018 (4) Swedish Asthma and Allergy Association?s Research Foundation grant no 2013049-K, PI, 2014-2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Torbjörn Tomson, PhD and
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Eisai speakers' honoraria to my institution. UCB speakers' honoraria to my institution. Livanova speakers' honoraria to my institution

    Editorial Boards:

    1. Epileptic Disoreder current Associate Editor

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. GSK, UCB, Eisai, Bial, Novartis research grants to EURAP

    Research Support, Government Entities:

    1. Stockholm County Council

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. CURE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Jonas F. Ludvigsson, PhD
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. European Journal of Epidemiology [roughly 2013-] Alimentary Pharmacology Therapeutics [roughly 2012-]

    Patents:

    1. NONE

    Publishing Royalties:

    1. Only Swedish publishers: Books related to either pediatrics or epidemiology: 1. att b?rja forska (Studentlitteratur), 2015 2. akutpediatrik (Liber), 2010 3. barnmedicin i ett n?tskal (Studentlitteratur), 2004

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Pediatrics (H.E.K.S.), Linköping University Hospital; Departments of Medical Epidemiology and Biostatistics (Z.C., H.L., P.L., C.A., J.F.L.) and Clinical Neuroscience (T.T.), Karolinska Institutet; Astrid Lindgren Children's Hospital (C.A.), Karolinska University Hospital, Stockholm; Department of Pediatrics (J.F.L.), Örebro University Hospital, Sweden; Division of Epidemiology and Public Health, School of Medicine (J.F.L.), University of Nottingham, UK; and Department of Medicine (J.F.L.), Columbia University, New York, NY.
  1. Correspondence
    Dr. Sundelin helene.sundelin{at}hotmail.com
View Full Text

Article usage

Article usage: February 2018 to April 2022

AbstractFullPdfSource
Feb 20182703Highwire
Mar 201819149077Highwire
Apr 201810276036Highwire
May 20181742016Highwire
Jun 2018170816Highwire
Jul 20185546Highwire
Aug 20186246Highwire
Sep 20187666Highwire
Oct 20189994Highwire
Nov 201876104Highwire
Dec 20186122Highwire
Jan 20197746Highwire
Feb 20196683Highwire
Mar 201968105Highwire
Apr 20194711Highwire
May 20195775Highwire
Jun 20195222Highwire
Jul 20196722Highwire
Aug 20194461Highwire
Sep 20194241Highwire
Oct 20194621Highwire
Nov 20194021Highwire
Dec 20193000Highwire
Jan 20203623Highwire
Feb 20204411Highwire
Mar 20202931Highwire
Apr 20203745Highwire
May 20205516Highwire
Jun 20204012Highwire
Jul 20201810Highwire
Aug 20201862Highwire
Sep 20204651Highwire
Oct 20203900Highwire
Nov 20204732Highwire
Dec 20204023Highwire
Jan 20214442Highwire
Feb 20212333Highwire
Mar 20216522Highwire
Apr 20214831Highwire
May 20214360Highwire
Jun 20215022Highwire
Jul 20215531Highwire
Aug 20216221Highwire
Sep 20217500Highwire
Oct 20215330Highwire
Nov 20218264Highwire
Dec 20215201Highwire
Jan 20227600Highwire
Feb 20226710Highwire
Mar 20224833Highwire
Apr 20226221Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me